'Real Appetite' For User Fees Among Energy & Commerce Democrats
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
Committee members' current priorities do not include authorizing user fee programs for the OTC monograph process or supplement GMP inspections, but proposals could get traction. "We think it is a happy medium of getting FDA the resources it needs," says Tiffany Guarascio, minority chief of staff.
You may also be interested in...
All Roads For OTC Policy Improvements Lead To User Fees, FDA Suggests
In an update on discussions with industry about potential user fees to support FDA's OTC monograph program, CDER officials say "industry and public would suffer" absent new fees.
All Roads For OTC Policy Improvements Lead To User Fees, FDA Suggests
During update on user fee discussions with industry to support FDA's OTC monograph program work, CDER officials say "industry and public would suffer" absent new fees.
All Roads For OTC Policy Improvements Lead To User Fees, FDA Suggests
During update on user fee discussions with industry to support FDA's OTC monograph program work, CDER officials say "industry and public would suffer" absent new fees.